|
prevention programs, outcomes/quality improvement, and quality
of life studies. We conduct both industry-sponsored and
federally funded clinical trials.
The
CAMC Institute Clinical Trials Center is a centralized clinical
research center dedicated to research full-time, and is
affiliated with West Virginia University, providing superior
patient care and clinical trial performance. The Center
is experienced in conducting Phase II-IV clinical trials
evaluating a myriad of therapeutic areas. It gives area
patients access to investigational drugs, innovative procedures,
and new therapies, reducing their need to travel outside
West Virginia for care. Some highlights of the Center are:
- Research
staff is available 24 hours a day, seven days a week,
for protocol-specific patient care.
- Complete
adherence to FDA regulations
- Protocol
adherence
- In
full compliance with GCPs and GLPs
- Complete
set of SOPs
- Our
clinical investigators are board-certified and our organization
is well-versed in FDA regulations and guidelines.
- Secured
investigational drug service space and drug storage
- Secured
storage space for case report forms and other study-related
documents
- Computerized
patient database
- Computerized
multi-disciplinary investigator database
- CLIA-
and CAP-approved laboratory (CAMC)
The
CAMC Institute is a CAMC, Inc., subsidiary, which includes
hospitals, primary care facilities, subspecialty practices,
a university affiliation, a children's hospital, and nursing
homes. We can provide virtually any patient population in
a variety of settings. Because of our affiliation with Charleston
Area Medical Center, we have access to over 550 physicians
and surgeons.
About
80% of the Center's studies come from industry or cooperative
groups, including the National Cancer Institute's network
affiliates. The remaining 20% are generated by local investigators.
The Center is involved in many national, multicenter studies.
The
CAMC Institute Clinical Trials Center provides a focused
mechanism for evaluating new drugs and drug uses, new medical
devices, and quality of life aspects associated with the
use of these products. These studies are conducted within
our own facilities as well as at hospitals, clinics, and
physicians' offices. The Institute plays an essential role
in encouraging and supporting quality research in a controlled
medical setting.
The
CAMC Institute Clinical Trials Center is an obvious choice
for today's researcher. Our current involvement includes
clinical trials of drugs and devices, prevention programs,
outcomes/quality improvement, and quality of life studies.
We conduct both industry-sponsored and federally funded
clinical trials. These projects have been implemented in
a variety of therapeutic areas including cardiology, oncology,
infectious diseases, endocrinology/metabolism, gynecology,
surgery, and device development.
The
Center also offers centralized management for clinical trials,
providing a single point of contact to sponsors and contract
research organizations. In addition, a centralized institutional
research and grants review office is available for prompt
human subject and contract review.
West
Virginia statistics indicate that the state's rates of heart
disease and stroke mortality have been higher than the national
average for the past three decades, and the gap between
the state and nation continues to widen. Helping CAMC, Inc.,
reduce these dismal statistics is central to the Clinical
Trials Center's mission. Recent efforts aimed at reducing
cardiovascular morbidity and mortality have attracted studies
on reducing restenosis rates after angioplasty and treating
patients with unstable angina and MI.
We are
interested in conducting research that will benefit the
people of West Virginia. The application of what we learn
from research is vital to the improvement of the health,
quality of service, and patient care throughout West Virginia.
As a system, we at CAMC, Inc., are dedicated to providing
the latest in new therapies and applications. As professionals
in a growing research testing center, we make our facilities
and resources available for clinical research studies.
Through
research, education, intervention, and health promotion,
we can change lives and improve the health of the people
we serve. Services performed by the CAMC Institute Clinical
Trials Center are multifaceted, improving health care opportunities
for CAMC, Inc., professionals and patients. Research projects
support CAMC, Inc., focus on health promotion and prevention.
On the
preventive front, the CAMC Institute Clinical Trials Center
was chosen as one of three sites in the nation to participate
in a two-year smoking cessation trial. One hundred and eighty-four
West Virginians participated in this trial.
CAMC
Institute's Clinical Trials Center has established a reputation
for conducting clinical trials efficiently and effectively.
Our investigators are experienced with clinical trials and
have a broad range of specialties. We also have experienced
certified clinical research coordinators, research nurse
coordinators, research assistants, and support staff. Biostatistical
assistance and study analysis is available through the CAMC
Institute, as well as research assistance for preparation
of institutional review board and other regulatory documentation.
We are also very experienced in budget preparation and study
implementation.
Our
patient referral base and our continually expanding computerized
database assure rapid patient screening and enrollment.
Our affiliations with hospitals, clinics, managed care,
extended care facilities and private physicians help to
provide an aggressive, cost-efficient approach to patient
recruitment.
All
studies are conducted by trained coordinators and investigators
according to rigorous quality standards.
Research
Support Services:
- Patient
recruitment and follow-up
- Centralized
site management for clinical trials
- Experienced
and certified study coordinators
- Core
research support staff
- Preparation
for site qualification
- Study
implementation
- Study
analysis
- Research
assistance for preparation of IRB and regulatory documents
- Identification
of research opportunities
- Study
recruitment
- Referral
education
- Advertising
- Teaching/inservice
of staff nurses, physicians, allied health, and patients
and their families
- Data
collection and management; data storage
- Study
medication and study device responsibility; pharmacy liaison
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
The
CHERI Clinical Trials Center has been involved with clinical
research for 17 years. We conduct studies in Phases II,
III, IIIb/IV in:
- Cardiology
(both device and drug)
- Endocrinology/Metabolism
- Internal
Medicine
- Hematology/Oncology
- Infectious
Disease
- Neurology
- OB-GYN
- Pain
Management
- Pediatrics
- Reproductive
Medicine
- Respiratory
Disease/Pulmonology
- Smoking
Cessation
- Surgery
Sponsors
we have worked with:
- Advanced
Cardiovascular Systems, Inc.
- The
Agency for Health Care Policy and Research (AHCPR)
- Alexion
Pharmaceuticals
- Amgen
- Arterial
Vascular Engineering, Inc.
- Boston
Scientific Corporation
- Bristol-Myers
Squibb Company
- Centocor
- Cordis
- Eastern
Cooperative Oncology Group (National Cancer Institute)
- Eli
Lilly
- Embol-X
- Genentech
- Gilead
Sciences
- Glaxo
Wellcome
- Guidant
Corporation
- Hoechst
Marion Roussel
- Hoffman-LaRoche,
Inc.
- I.D.D.S.
Inc.
- ImClone
Systems Inc.
- Johnson
and Johnson
- Medtronic
AVE
- National
Heart, Lung & Blood Institute (NHLBI)
- National
Surgical Adjuvant Breast and Bowel Project (National Cancer
Institute)
- Novartis
- Ortho-McNeill
- Parke-Davis
- Pediatric
Oncology Group (National Cancer Institute)
- Pfizer
- Rhone-Poulenc
Rorer
- Sanofi
- Schering-Plough
Corporation
- Schneider
- Shelhigh,
Inc.
- SmithKline
Beecham
- Southwest
Oncology Group (National Cancer Institute)
- St.
Jude Medical
- Texas
Biotechnology
- 3
M
CROs
we have worked with:
- Advanced
Biologics
- Bailer
Research
- Clin
Trials
- Clinical
Research Partners, Inc.
- Covance
- ICON
Clinical Research
- Kern
McNeill International
- Paragon
Biomedical
- Parexel
International Corporation
- Pharmaceutical
Research Associates
- The
Phoenix
- PPD
Pharmaco
- PPD
Development
- Quintiles,
Inc.
- Quintiles
Pacific, Inc.
- Scirex
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
The
CAMC Institute Clinical Trials Center, with its affiliation
to Charleston Area Medical Center (CAMC), West Virginia's
largest health care provider, and West Virginia University,
is an obvious choice for today's researcher. CAMC is fully
accredited by Joint Commission for the Accreditation of
Health Care Organizations (JCAHO). In addition, the medical
center is affiliated with many other hospitals and health
care facilities throughout the state and serves southern
West Virginia's population of more than 500,000. Demographically,
the population is broadly distributed among all age, education,
and income groups. We have the capabilities of conducting
outpatient studies within the CAMC Institute Clinical Trials
Center. The center is equipped with full service exam rooms
and laboratory, an EKG machine, locked storage for investigational
drugs and devices, refrigerator for temporary storage of
drug and/or specimens, and secure storage for CRFs. In addition,
we are able to conduct inpatient studies at Charleston Area
Medical Center. CAMC is a 900 bed full service hospital
with a dedicated Investigational Drug Pharmacist. Geographically,
we are five minutes from Yeager Airport, and 2-4 hours from
several major cities, including Pittsburgh, Columbus, and
Cincinnati.
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
Ali
F. AbuRahma, M.D.
Peripheral Vascular and Vascular Surgery, General Surgery
Mario
R. Balmaseda, M.D.
Physical Medicine and Rehabilitation
Mark
C. Bates, M.D.
Cardiovascular Disease
James
P. Boland, M.D.
General Surgery, Vascular Surgery, Trauma, Thoracic and
Cardiovascular Surgery
John
L. Chapman, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
Justin
D. Cohen, M.D.
Hematology/Oncology
Michael
A. Covelli, M.D.
General Surgery, Surgical Oncology, Vascular Surgery
Nestor
F. Dans, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
John
A. DeLuca, M.D.
General Surgery, Vascular Surgery, Trauma
James
N. Frame, M.D.
Hematolory/Oncology
John
L. Goad, M.D.
Cardiovascular Disease
Gordon
Green, M.D.
Pediatrics and Emergency Medicine
Edward
J. Grey, M.D.
Pulmonary Disease
Stephen
R. Grubb, M.D.
Endocrinology, Diabetes, and Metabolism
Omar
K. Hallak, M.D.
Cardiovascular Disease
Michael
B. Harman, M.D.
Radiation Oncology
Sulaiman
B. Hasan, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
S.
Greg Heywood, M.D.
Obstetrics and Gynecology
Stephen
Jubelirer, M.D.
Hematology/Oncology
James
W. Kessel, M.D.
General Surgery, Vascular Surgery, Trauma
Jamal
H. Khan, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
M.
Zafrullah Khan, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
Raheel
R. Khan, M.D.
Pediatric Infectious Diseases
Jay
J. Kim, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
Kiren
J. Kresa-Reahl, M.D.
Neurology
Kee
C. Lee, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
Stephen
A. Lewis, M.D.
Cardiovascular Disease
Donald
R. Lilly, M.D.
Cardiovascular Disease
B.
Daniel Lucas, Pharm. D.
Cardiovascular Pharmacology/Outcomes/Pharmacoeconomics
Frank
C. Lucente, M.D.
General Surgery, Vascular Surgery, Trauma
Firasat
S. Malik, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
Eric
P. Mantz, M.D.
General Surgery, Vascular Surgery
Ronald
McCowan, M.D.
Cardiovascular Disease, Clinical Cardiac Electrophysiology
Kathleen
Mimnagh, M.D.
Internal Medicine, Emergency Medicine
Norman
Montalto, D.O.
Family Practice
Kurt
M. Nelhaus, M.D.
Critical Care Medicine and Pulmonary Disease
Frederic
H. Pollock, M.D.
Orthopedics
Humayun
Rashid, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
M.
Salim Ratnani, M.D.
Thoracic and Cardiovascular Surgery, Vascular Surgery
Harry
L. Reahl, M.D.
Neurology
J.
Gregory Rosencrance, M.D.
Internal Medicine
Ron
Sarken, M.D.
Hematology/Oncology
David
E. Seidler, M.D.
Emergency Medicine
Arvin
B. Shah, M.D.
Hematology/Oncology
A.
Christine Teague, Pharm.D.
Pharmacy/Infectious Diseases
Jashvantlal
K. Thakkar, M.D.
Cardiovascular Disease
James
P. Tierney, D.O.
Urology
S.
Willis Trammell, M.D.
General Surgery, General Vascular Surgery
N.
Andrew Vaughan, M.D.
Cardiovascular Disease
Stafford
G. Warren, M.D.
Cardiovascular Disease
Todd
A. Witsberger, M.D.
General Surgery, General Vascular Surgery, Trauma
Feredoun
Zangeneh, M.D.
Pediatric Endocrinology
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
Holly
Blackwood, RN, BSN
Clinical Research Coordinator
2+ years experience in clinical research
Abdul
Karim Elhabyan
Clinical Research Fellow
Joy
S. Hogan, LPN Ph
Clinical Research Coordinator
4 months experience in clinical research
B.
Daniel Lucas, Jr. Pharm.D.
Director, Centers for Clinical Sciences Research
8 years experience in clinical research
Lisa
Luikart, B.B.A.
Clinical Research Coordinator
3 years experience in clinical research
Jean
Matthews, RN
Clinical Research Coordinator
4 months experience in clinical research
Sandi
Mitchell
Staff Assistant
1 year experience in clinical research
Barbara
Resler, RN, MSN
Clinical Research Coordinator
1 year experience in clinical research
Kristi
Denison Sutphin, B.B.A.
Clinical Research Coordinator
1 year experience in clinical research
Cyndi
Tignor, RN
Clinical Research Coordinator
1 year experience in clinical research
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
Charleston
Area Medical Center (CAMC) serves Southern West Virginia's
population of more than 500,000. Demographically, the population
is broadly distributed among all age, educational, and income
groups. According to the U.S. Census Bureau, West Virginia's
population has the highest median age (37.7) in the nation,
and ranks fourth in the United States in the proportion
of its population that is elderly (65+). In addition, women
compose a larger percentage of the population in West Virginia
than in the nation as a whole (53.1%).
According
to the 1998 West Virginia County Health Profiles, West Virginia
ranks higher in a national comparison in the following areas:
- Cardiovascular
diseases
- All
cancers
- Chronic
obstructive pulmonary disease (COPD)
- Unintentional
injuries
- Diabetes
mellitus
- Chronic
smoking (ranked 7th for adults and 1st for high school
students in nation)
- Smokeless
tobacco use (ranked 1st in nation)
- Obesity
(ranked 7th in nation)
- Hypertension
- Sedentary
lifestyles (ranked 4th in nation)
West
Virginia residents exhibit behavioral risk factors well
above the national average, and the risk factors in CAMC's
referral region exceed the state average.
- Total
cardiovascular diseases are the most common cause of death
in the state, accounting for 40% of all deaths. West Virginia
is ranked 4th in the nation for rates of death due to
total cardiovascular diseases.
- Cancer
is the second most common cause of death in the state,
accounting for 25% of all deaths in West Virginia. Lung
cancer (WV ranked 1st in the nation for rates of death
due to lung cancer), colorectal cancer (WV ranked 19th
for rates of death due to colorectal cancer), and breast
cancer (WV ranked 43rd for rates of death due to breast
cancer) are the three most common killers in the state.
West Virginia is ranked 7th in the nation for rates of
death due to all cancers. Southern West Virginia has a
significantly higher incidence of lung cancer than the
rest of the nation, particularly among males (23% versus
13%).
- COPD
is the third most common cause of death in West Virginia.
The state is ranked 1st in the nation for rates of death
due to COPD.
- Diabetes
is the fifth most common cause of death in WV. It affects
more than 25% of West Virginians by the time they reach
65 years of age. The state is ranked 10th in the nation
for rates of death due to diabetes.
- Prevalence
of end-stage renal disease in West Virginia is markedly
higher than the national rate.
- Estimates
of men and women in West Virginia aged 50 and over who
have osteoporosis are higher than national estimates.
- West
Virginia's overall death rate was ranked 1st in the nation
in 1996.
- West
Virginia ranked 30th in the nation for rates of death
due to stroke.
In
addition, CAMC was rated as one of the best facilities
for neurosciences and neurology in U.S. News and World Report's
1999 guide to America's Best Hospitals. Out of 50 health
care facilities acknowledged for excellence in neurology
and neurosciences in the U.S., CAMC was ranked 35th.
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
Our
staff is experienced with using Remote Data Entry.
%20CAMC%20Institute%20;%20Charleston,%20WV_files/blu_line.gif)
For
more information, please contact:
Clinical Trials Operations Manager
CAMC Institute
Clinical Trials Center
3100 MacCorkle Avenue, S.E.
Suite 306
Charleston, WV 25304 USA
Phone: 304-388-9934
Fax: 304-388-9935
E-mail: dan.lucas@camc.org
|